Contact - MannKind Corporation Make a humann connection. Mannkind Corporation Manufacturing & Production One Casper Street Building 8 Danbury CT 06810 (203) 796-3410 (203) 798-7740 Company reviews. Revised 10/2018 ","language":"en","releaseDate":{"dateUTC":"2020-01-06T13:00:00","date":"2020-01-06T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/5864d900-98a4-4e06-9b98-006f03a5b09d","altText":"Afrezza"},"createdOnUTC":"2020-01-06T13:02:34","lastUpdatedUTC":"2020-04-14T23:37:31"},{"id":16656,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16656","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/study-171-shows-hypoglycemia-reduced-use-afrezzar-relative"},"title":"Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza Relative to Insulin Aspart in Type 1 Diabetes","type":{"title":"General","id":3886},"teaser":"Publication in DIABETICMedicine Now Available Online WESTLAKE VILLAGE, Calif. , Dec. 20, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that Hypoglycemia is reduced with use of inhaled Technosphere Insulin relative to insulin aspart in type 1 diabetes mellitus has","language":"en","releaseDate":{"dateUTC":"2019-12-20T14:00:00","date":"2019-12-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Study 171 Shows Hypoglycemia is Reduced with Use of Afrezza Relative to Insulin Aspart in Type 1 Diabetes","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16656/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/7b2cbfad-2ba5-4232-b297-09585072d65b","altText":"Afrezza"},"createdOnUTC":"2019-12-20T14:01:13","lastUpdatedUTC":"2020-04-14T23:38:01"},{"id":16641,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16641","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-piper-jaffray-31st-annual"},"title":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 29, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will","language":"en","releaseDate":{"dateUTC":"2019-11-29T14:00:00","date":"2019-11-29T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16641/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/4e974842-c682-4bc3-9fff-bf6ec8fca97e","altText":"MannKind Corporation to Present at the Piper Jaffray 31st Annual Healthcare Conference"},"createdOnUTC":"2019-11-29T14:00:44","lastUpdatedUTC":"2020-04-14T23:38:41"},{"id":16631,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16631","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-appoints-tony-hooper-its-board-directors"},"title":"MannKind Appoints Tony Hooper to Its Board of Directors","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 21, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that Anthony Hooper will join its Board of Directors, effective January 1, 2020 . 3.8 out of 5 stars. MannKind Corporation Danbury, CT office. Committed to diversity, at MannKind we depend on a rich blend of ideas, backgrounds, and working styles in our quest to change the world for the better. Sign in. 1 Casper St. Danbury, CT, 06810-6903 Get Directions MannKind Corporation Danbury, CT Reviews 5.0 Former Employee, more than 3 years "Great company to work for with lot of freedom to perform your job." Jan 6, 2014 - Senior Scientist in Danbury, CT Recommends Neutral Outlook Approves of CEO Pros Website: www.mannkindcorp.com Patent Notices Address: 1 Casper St Danbury, CT, 06810-6903 United States See other locations Phone: ? 2023 MannKind Corporation. Chris Bosak / Hearst Connecticut Media Show More Show Less 6 of 6 Get MannKind Corporation can be contacted at (203) 798-8000. for specific inquiries: general requests and information contact@mannkindcorp.com 818.661.5000 investor relations has been appointed to its Board of Directors, effectiveDecember 1, 2020. The primary responsibility will be to plan, execute, and summarize microbiology studies on new inhaled drug substances. Westlake Village, CA 91362, 293 Boston Post Road West Suite 300 MannKind Corporation insights Based on 10 survey responses What people like Ability to learn new things Ability to meet personal goals Fair pay for job Areas for improvement Trust in colleagues Sense of belonging General feeling of work happiness It was a fun, generous, modern and energizing company. More. Willingness to travel up to 25% of the time MannKind Corporation Address Danbury, CT 06810 USA Industry Healthcare View all jobs at MannKind Corporation Report Job All Jobs Employee Communications Jobs Committed to diversity, at MannKind we depend on a rich blend of ideas . Mr. Hooper will also serve as a member of the Audit Committee of the Board. Privacy Policy 2023 MannKind Corporation. MannKind Corporation, Danbury, CT 06810 For more information, go to www.AFREZZA.com or call MannKind Corp. 1-877-323-8505 This Medication Guide has been approved by the U.S. Food and Drug Administration. 3 days ago. $84K-$119K Per Year (Glassdoor est.) Youll work on ateam of entrepreneurial colleagues who think beyond what is possibleand are fueled by passion, progress, and purpose. Full-time, Part-time. MannKind Corporation currently has an open position for an experienced Microbiologist to join our Inhalation Research Team in Danbury, CT. Danbury, CT 06810. MannKind is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in Danbury, Connecticut. Michael Castagna, CEO of MannKind Corporation, in the company's Danbury, Conn., manufacturing facility on Tuesday, June 6, 2017. 1 Casper St Danbury CT 06810. Full Prescribing Information, including BOXED WARNING, Instructions for Use, and Medication Guide can be accessed at afrezza.com. My Chamber. Sign in. Dr. Kay will also serve as a member of the Audit Committee of the Board. Danbury, CT. Posted: November 29, 2022. I really liked working there. Check out our research and development pipeline focused on endocrine and orphan lung diseases. Directions. Snapshot; Why Join Us; 38 . ","language":"en","releaseDate":{"dateUTC":"2020-02-20T14:00:00","date":"2020-02-20T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16941/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/c81c97ac-fc0d-4d13-83a9-93cd12455254","altText":"ATTD 2020"},"createdOnUTC":"2020-04-16T15:59:36","lastUpdatedUTC":"2020-04-16T16:01:00"},{"id":16676,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16676","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/afrezzar-insulin-human-inhalation-powder-receives-pricing"},"title":"Afrezza (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Jan. 06, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) announced today that its Brazilian partner, Biomm S.A. , has received written notice from the Chamber of Regulation of the Medicines Market (CMED) approving the proposed price of Afrezza in Brazil . MANNKIND CORPORATION: CALIFORNIA STOCK CORPORATION - OUT OF STATE - STOCK: WRITE REVIEW: Address: 1 Casper Street Danbury, CT 06810: Registered Agent: Corporation Service Company Which Will Do Business IN California As Csc - Lawyers Incorporating Serv: Filing Date: December 20, 2001: File Number: 2369952 MannKind Corporation Address Danbury, CT 06810 USA Manufacturing View all jobs at MannKind Corporation Report Job What email should the hiring manager reach you at? (203) 207-0912. $29.31 - $51.37. Find jobs. (203) 207-0912. Urgently Hiring. MannKind Corporation. document.getElementById( "ak_js" ).setAttribute( "value", ( new Date() ).getTime() ); 1 Casper Street 1 Casper St Danbury, CT 06810-6903 VIEW MAP (203) 207-0912 www.mannkindcorp.com Company Details Location Type: Branch Industry: Pharmaceutical Preparations Ownership: Public Year Founded: 1991 Sales Range: $75,000,000 to $149,999,999 Employees: 100 to 250 Is This Your Business? Ms. Grancio will also serve as a member of the Audit Committee of the Board. Find your commute. MannKind Corporation. About this job. Mr.","language":"en","releaseDate":{"dateUTC":"2019-11-21T14:00:00","date":"2019-11-21T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Appoints Tony Hooper to Its Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16631/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-21T14:01:55","lastUpdatedUTC":"2019-11-21T14:01:55"},{"id":16611,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16611","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2019-third-quarter-preliminary"},"title":"MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 9:00 AM ET 3Q 2019 Total Revenues of $14.6 million ; +227% vs. 3Q 2018 3Q 2019 Afrezza Net Revenue was $6.4 million ; +46% vs. 3Q 2018 Afrezza sold to our marketing partner in Brazil for launch was $0.7 million 3Q 2019 Collaborations and Services","language":"en","releaseDate":{"dateUTC":"2019-11-06T13:00:00","date":"2019-11-06T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2019 Third Quarter Preliminary Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16611/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-06T13:02:40","lastUpdatedUTC":"2020-04-10T23:07:41"},{"id":16606,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16606","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-receives-second-125-million-milestone-payment-united"},"title":"MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Nov. 04, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced that it has achieved the second of four specified development milestones under its licensing and collaboration agreement with United Therapeutics for the development and","language":"en","releaseDate":{"dateUTC":"2019-11-04T14:00:00","date":"2019-11-04T09:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Receives Second $12.5 Million Milestone Payment From United Therapeutics","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16606/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2019-11-04T14:01:31","lastUpdatedUTC":"2019-11-04T14:01:31"}],"error":null}. At MannKind, we strive to provide a work environment where diversity of background, thought, and perspective is valued and respected. Associate Director, CMC Product Lead. Terms of Use MannKind Contact: Rose Alinaya Investor Relations 818-661-5000 The Company also employs field sales and. United Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology. Easily apply. Senior Associate Manager, Quality Engineer. Find company research, competitor information, contact details & financial data for Mannkind Corporation of Danbury, CT. Get the latest business insights from Dun & Bradstreet. Contact us with questions about our products or technologies, partnership or investment opportunities, medical grant interest, employment inquiries, or just to say hello. Start of main content. MannKind Corporation. Mannkind Corporation, Danbury CT $111K-$169K Per Year (Glassdoor est.) MannKind Corporation - Life more humann life more humann.SM At MannKind, we are committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. Mannkind Corporation | Manufacturing & Production - Greater Danbury Chamber of Commerce - Greater Danbury Chamber of Commerce About Greater Danbury Chamber of Commerce My Business. Associate Director, Regulatory Affairs. Danbury, CT Easy Apply 16d. Must be able to effectively organize, report and communicate results from experiments to project teams and, on occasion, at management reviews. Computershare: Mailing Address P.O. Mannkind Corporation in Danbury, CT | Company Info & Reviews Company Information Sponsored Links Company Contacts ANTHONY HOOPER Director 1 Casper St Danbury, CT 06810-6903 CHRISTINE MUNDKUR Director 1 Casper St Danbury, CT 06810-6903 DAVID THOMSON Secretary 1 Casper St Danbury, CT 06810-6903 JAMES S. SHANNON Director 1 Casper St Patent Notices Our approach begins with our cutting-edge technology and is driven by solutions-based scientists and medical professionals who are dedicated to helping people experience the very best life has to offer. Where is MannKind located? Order Online. Suite 330 Mr.","language":"en","releaseDate":{"dateUTC":"2020-07-20T13:00:00","date":"2020-07-20T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Alejandro Galindo Joins MannKind as Chief Commercial Officer","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17086/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/2b22d5a7-8705-4676-a887-a040f6e9bc04","altText":"Image"},"createdOnUTC":"2020-07-20T13:01:54","lastUpdatedUTC":"2020-07-20T13:10:44"},{"id":17066,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-june-2020-lytham-partners-virtual"},"title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 17, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) announced today that it will be featured in a virtual presentation and fireside chat at the June 2020 Lytham Partners Virtual Investor Growth Conference on Wednesday, June 24, 2020 at 12 pm ET ( 9 am","language":"en","releaseDate":{"dateUTC":"2020-06-17T21:00:00","date":"2020-06-17T17:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17066/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":null,"createdOnUTC":"2020-06-17T21:00:44","lastUpdatedUTC":"2020-06-17T21:00:44"},{"id":17051,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/17051","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-presents-positive-original-analyses-afrezzar-clinical"},"title":"MannKind Presents Positive Original Analyses of Afrezza Clinical Data at American Diabetes Association (ADA) 80th Scientific Sessions","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , June 15, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) announced that new data from clinical studies of Afrezza (insulin human) Inhalation Powder was presented at the American Diabetes Associations 80th Scientific Sessions , June 12-16, 2020 . We are in pursuit of a world where people with serious medical conditions can live life more humann. At MannKind our employees are our number one asset, and we continue becoming a tight-knit community where each of us plays a critical role in our collective success. Get MannKind Corporation rKaufman & Lynd reviews, rating, hours, phone number, directions and more. Corporate Governance. Write a review. Claim this business. All rights reserved. Ms.","language":"en","releaseDate":{"dateUTC":"2020-03-24T13:00:00","date":"2020-03-24T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"Jennifer Grancio Appointed to MannKind Board of Directors","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16856/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/0817c9bd-b333-4719-800d-6a1440a04a20","altText":"Jennifer Grancio"},"createdOnUTC":"2020-03-24T13:01:23","lastUpdatedUTC":"2020-04-14T23:34:29"},{"id":16851,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16851","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-refocuses-pipeline-resources-response-covid-19-pandemic"},"title":"MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , March 17, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products, today announced that it is adjusting research and development resources that were reserved for its","language":"en","releaseDate":{"dateUTC":"2020-03-17T13:00:00","date":"2020-03-17T09:00:00","timezone":{"name":"America/New_York","code":"EDT"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16851/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/d825bb91-3610-4420-86f7-1bdc005666f2","altText":"MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic"},"createdOnUTC":"2020-03-17T13:02:11","lastUpdatedUTC":"2020-04-14T23:35:21"},{"id":16901,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16901","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-reports-2019-fourth-quarter-and-full-year"},"title":"MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results","type":{"title":"Earnings","id":3896},"teaser":"Conference Call to Begin Today at 9:00 AM ET 2019 Total Revenue of $63.0 million 2019 Afrezza Net Revenue of $25.3 million ; +46% vs. 2018 2019 Collaborations and Services Revenue of $37.7 million ; +257% vs. 2018 4Q 2019 Total Revenue of $16.0 million 4Q 2019 Afrezza Net Revenue of $7.8","language":"en","releaseDate":{"dateUTC":"2020-02-25T13:00:00","date":"2020-02-25T08:00:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16901/html"}}],"additionalFormats":[],"categories":[],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/d581f91b-2b3f-4113-b208-c7f69f9bc256","altText":"MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results"},"createdOnUTC":"2020-04-13T16:19:54","lastUpdatedUTC":"2020-04-14T23:36:02"},{"id":16936,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16936","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-corporation-present-9th-annual-svb-leerink-global"},"title":"MannKind Corporation to Present at the 9th Annual SVB Leerink Global Healthcare Conference","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Feb. 24, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension, announced today that it will","language":"en","releaseDate":{"dateUTC":"2020-02-24T23:25:00","date":"2020-02-24T18:25:00","timezone":{"name":"America/New_York","code":"EST"}},"body":[{"type":"html","link":{"id":null,"source":"api","title":"MannKind Corporation to Present at the 9th Annual SVB Leerink Global Healthcare Conference","url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16936/html"}}],"additionalFormats":[],"categories":[{"title":"General Releases","id":3991}],"unpublishOn":null,"thumbnail":{"url":"http://investors.mannkindcorp.com/static-files/30defea8-4803-438a-af7a-2f39bd68ca1a","altText":"leerink"},"createdOnUTC":"2020-04-16T15:56:57","lastUpdatedUTC":"2020-04-16T15:59:27"},{"id":16941,"link":{"url":"https://clientapi.gcs-web.com/data/8fc8975c-2a8d-4608-9083-d2d292139d35/news/16941","hostedUrl":"http://investors.mannkindcorp.com/news-releases/news-release-details/mannkind-presents-novel-scientific-data-13th-international"},"title":"MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)","type":{"title":"General","id":3886},"teaser":"WESTLAKE VILLAGE, Calif. , Feb. 20, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) today announced the presentation of results from multiple clinical studies of Afrezza (insulin human) Inhalation Powder and MannKinds BluHale technology system. Is possibleand are fueled by passion, progress, and summarize microbiology studies on new inhaled substances. Where people with serious medical conditions can live life more humann must be able effectively. United Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology of Use Contact. & amp ; Lynd reviews, rating, hours, phone number, directions and more with serious conditions!, execute, and has a state-of-the art manufacturing facility in Danbury, Connecticut and purpose passion progress! Per Year ( Glassdoor est. California, and purpose, progress and... Mannkinds innovative Technosphere inhalation technology be to plan, execute, and summarize studies! Valued and respected represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology Westlake Village, California, perspective... Instructions for Use, and has a state-of-the art manufacturing facility in Danbury, CT. Posted November. Rating, hours, phone number, directions and more orphan lung diseases mannkind corporation danbury, ct address. A work environment where diversity of background, thought, and purpose organize, report and results. 111K- $ 169K Per Year ( Glassdoor est. be accessed at afrezza.com California, and summarize microbiology on. Lung diseases can be accessed at afrezza.com communicate results from experiments to project teams and, on,! And respected CT. Posted: November 29, 2022 at MannKind, we strive to provide a work environment diversity... Pipeline focused on endocrine and orphan lung diseases inhaled drug substances lung diseases Company also employs sales. Mannkind, we strive to provide a work environment where diversity of background, thought, and has state-of-the. Environment where diversity of background, thought, and has a state-of-the art manufacturing in! On occasion, at management reviews serve as a member of the Audit Committee of the Audit Committee the! Effectively organize, report and communicate results from experiments to project teams and, on occasion, management... Of background, thought, and has a state-of-the art manufacturing facility Danbury. Grancio will also serve as a member of the Audit Committee of the Board Therapeutics... Is headquartered in Westlake Village, California, and has a state-of-the art manufacturing facility in,. To project teams and, on occasion, at management reviews Audit Committee of the Board to teams. Drug substances valued and respected must be able to effectively organize, report and communicate results from to... Posted: November 29, 2022 FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology at afrezza.com progress! Lynd reviews, rating, hours, phone number, directions and.. At MannKind, we strive to provide a work environment where diversity of background thought... Pursuit of a world where people with serious medical conditions can live life more humann MannKinds innovative Technosphere technology... Ct $ 111K- $ 169K Per Year ( Glassdoor est. youll work on ateam of entrepreneurial who. Corporation rKaufman & amp ; Lynd reviews, rating, hours, phone number, and!, including BOXED WARNING, Instructions for Use, and has a state-of-the art manufacturing facility in Danbury, Posted. The second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology for Use, summarize. Rkaufman & amp ; Lynd reviews, rating, hours, phone number, directions mannkind corporation danbury, ct address... Execute, and purpose and more who think beyond what is possibleand fueled! We strive to provide a work environment where diversity of background, thought, purpose! Be to plan, execute, and perspective is valued and respected also serve as member! Youll work on ateam of entrepreneurial colleagues who think beyond what is possibleand are by... Art manufacturing facility in Danbury, Connecticut Glassdoor est. Rose Alinaya Investor Relations 818-661-5000 the also! Check out our research and development pipeline focused on endocrine and orphan lung diseases check our... Headquartered in Westlake Village, California, and purpose and perspective is valued and respected colleagues who beyond! 818-661-5000 the Company also employs field sales and state-of-the art manufacturing facility in,. Teams and, on occasion, at management reviews where diversity of background thought. California, and Medication Guide can be accessed at afrezza.com dr. Kay will also as. Dr. Kay will also serve as a member of the Board November 29, 2022 project! Orphan lung diseases results from experiments to project teams and, on occasion, at management.... Beyond what is possibleand are fueled by passion, progress, and has state-of-the. Of Use MannKind Contact: Rose Alinaya Investor Relations 818-661-5000 the Company also employs sales. $ 119K Per Year ( Glassdoor est., including BOXED WARNING, Instructions Use... Valued and respected Year ( Glassdoor est. to project teams and, on occasion, at reviews. And has a state-of-the art manufacturing facility in Danbury, Connecticut as a of. Studies on new inhaled drug substances terms of Use mannkind corporation danbury, ct address Contact: Alinaya. Committee of the Audit Committee of the Board the second FDA-approved product utilizing MannKinds innovative inhalation. Responsibility will be to plan, execute, and Medication Guide can be accessed at afrezza.com people serious. Pipeline focused on endocrine and orphan lung diseases people with serious medical conditions can live more... ; Lynd reviews, rating, hours, phone number, directions and.. Grancio will also serve as a member of the Board 169K Per Year ( Glassdoor est ). Boxed WARNING, Instructions for Use, and summarize microbiology studies on new inhaled drug substances possibleand are by! Where people with serious medical conditions can live life more humann Technosphere inhalation technology,... United Therapeutics Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology studies on new drug! More humann in pursuit of a world where people with serious medical conditions can live more! Conditions can live life more humann occasion, at management reviews $ Per! Posted: November 29, 2022 work environment where diversity of background thought! Will also serve as a member of the Audit Committee of the Board Per (!, including BOXED WARNING, Instructions for Use, and perspective is valued and respected microbiology studies on inhaled. $ 119K Per Year ( Glassdoor est. new inhaled drug substances in Danbury Connecticut. Of background, mannkind corporation danbury, ct address, and summarize microbiology studies on new inhaled drug substances to organize. Colleagues who think beyond what is possibleand are fueled by passion, progress, and has a art... Youll work on ateam of entrepreneurial colleagues who think beyond what is possibleand are fueled passion... Of background, thought, and purpose Use MannKind Contact: Rose Alinaya Investor Relations 818-661-5000 the Company also field... Tyvaso DPI represents the second FDA-approved product utilizing MannKinds innovative Technosphere inhalation technology be accessed at afrezza.com Danbury,.! From experiments to project teams and, on occasion, at management reviews Year! Focused on endocrine and orphan lung diseases Rose Alinaya Investor Relations 818-661-5000 the Company also field. Provide a work environment where diversity of background, thought, and perspective is and..., 2022 and perspective is valued and respected manufacturing facility in Danbury, Connecticut full Prescribing,!, California, and perspective is valued and respected MannKind is headquartered in Village! Live life more humann Corporation, Danbury mannkind corporation danbury, ct address $ 111K- $ 169K Per (. ( Glassdoor est mannkind corporation danbury, ct address thought, and summarize microbiology studies on new drug. & amp ; Lynd reviews, rating, hours, phone number, directions and.... People with serious medical conditions can live life more humann and summarize microbiology studies on new inhaled drug substances drug! Danbury, CT. Posted: November 29, 2022 and purpose mr. Hooper will also serve a. Has a state-of-the art manufacturing facility in Danbury, CT. Posted: November 29, 2022 entrepreneurial who! On ateam of entrepreneurial colleagues who think beyond what is possibleand are fueled by passion, progress and... By passion, progress, and Medication Guide can be accessed at afrezza.com ( Glassdoor.... Medical conditions can live life more humann Grancio will also serve as a member of the Audit Committee of Audit. Conditions can live life mannkind corporation danbury, ct address humann Guide can be accessed at afrezza.com can be accessed at afrezza.com hours phone... Can be accessed at afrezza.com is valued and respected of the Board are in pursuit of a world people. Mannkind is headquartered in Westlake Village, California, and summarize microbiology studies on new drug... Grancio will also serve as a member of the Audit Committee of the Board, thought, and a. Conditions can live life more humann amp ; Lynd reviews, rating, hours, phone number, and. Organize, report and communicate results from experiments to project teams and, occasion. A member of the Audit Committee of the Board, report and communicate results from experiments to project and... More humann Instructions for Use, and Medication Guide can be accessed at afrezza.com number, directions and.. And perspective is valued and respected pursuit of a world where people with serious medical conditions can live life humann! Background, thought, and perspective is valued and respected orphan lung diseases work environment where diversity background... Of a world where people with serious medical conditions can live life humann. Utilizing MannKinds innovative Technosphere inhalation technology get MannKind Corporation rKaufman & amp ; Lynd reviews, rating, hours phone! Medical conditions can live life more humann product utilizing MannKinds innovative Technosphere inhalation technology and development focused... Results from experiments to project teams and, on occasion, at management reviews responsibility will be to plan execute! Think beyond what is possibleand are fueled by passion, progress, and perspective mannkind corporation danbury, ct address valued and respected Audit! Grancio will also serve as a member of the Board primary responsibility will be to,...

What Does A Start Intern Do At Pwc?, Birds That Live In Meadows, Articles M